Advertisement
Screener

BRUKER CORPORATION (BRKR) Restructuring Reserve, Foreign Currency Translation Gain (Loss)

2.8 / 5 stars · 68/120 Roast Me

BRUKER CORPORATION Restructuring Reserve, Foreign Currency Translation Gain (Loss)

BRUKER CORPORATION (BRKR) reported Restructuring Reserve, Foreign Currency Translation Gain (Loss) of -$400.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.

Financial Statements › Notes › Restructuring and Related Activities

us-gaap:RestructuringReserveTranslationAdjustment · last filed 2026-05-07

  • BRUKER CORPORATION restructuring reserve, foreign currency translation gain (loss) for the quarter ending 2026-03-31 was -$400.00K.
  • BRUKER CORPORATION restructuring reserve, foreign currency translation gain (loss) for the quarter ending 2015-03-31 was -$1.50M.
  • BRUKER CORPORATION restructuring reserve, foreign currency translation gain (loss) for the quarter ending 2014-12-31 was -$300.00K, a 175.00% decline year-over-year.
  • BRUKER CORPORATION restructuring reserve, foreign currency translation gain (loss) for the quarter ending 2013-12-31 was $400.00K.
  • BRUKER CORPORATION restructuring reserve, foreign currency translation gain (loss) for fiscal 2025 was $800.00K.
  • BRUKER CORPORATION restructuring reserve, foreign currency translation gain (loss) for fiscal 2024 was -$300.00K, a 400.00% decline from fiscal 2023.
  • BRUKER CORPORATION restructuring reserve, foreign currency translation gain (loss) for fiscal 2023 was $100.00K.
  • BRUKER CORPORATION restructuring reserve, foreign currency translation gain (loss) for fiscal 2022 was -$200.00K.
Period endRestructuring Reserve, Foreign Currency Translation Gain (Loss) 3 monthRestructuring Reserve, Foreign Currency Translation Gain (Loss) 6 monthRestructuring Reserve, Foreign Currency Translation Gain (Loss) 9 monthRestructuring Reserve, Foreign Currency Translation Gain (Loss) 12 monthRestructuring Reserve, Foreign Currency Translation Gain (Loss) 12 month as first filed
2026-03-31-$400.00K
10-Q · filed 2026-05-07
2025-12-31$800.00K
10-K · filed 2026-02-27
2024-12-31-$300.00K
10-K · filed 2026-02-27
2023-12-31$100.00K
10-K · filed 2026-02-27
2022-12-31-$200.00K
10-K · filed 2025-03-03
$200.00K
10-K · filed 2023-03-01
2021-12-31-$200.00K
10-K · filed 2024-02-29
2020-12-31$400.00K
10-K · filed 2023-03-01
2019-12-31-$200.00K
10-K · filed 2022-02-28
2018-12-31-$200.00K
10-K · filed 2021-03-01
2017-12-31$1.00M
10-K · filed 2020-03-27
2016-12-31-$200.00K
10-K · filed 2019-03-01
2015-12-31-$1.40M
10-K · filed 2018-03-16
2015-03-31-$1.50M
10-Q · filed 2015-05-08
-$1.80M
derived: sum of 2 quarters · filed 2017-03-01
2014-12-31-$300.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
-$1.10M
10-K · filed 2017-03-01
2014-09-30-$800.00K
10-Q · filed 2014-11-07
2013-12-31$400.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$500.00K
10-K · filed 2015-02-27
2013-09-30$100.00K
10-Q · filed 2013-11-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
Avantor, Inc. (AVTR)United States$10.501B-9.72
REVVITY, INC. (RVTY)United States$16.814B53.44
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34